Jason Colodne and Colbeck Capital Sponsor the Children's Tumor Foundation 2025 National Gala

NEW YORK--(BUSINESS WIRE)--Colbeck Capital Management (“Colbeck”) today announced support of the Children’s Tumor Foundation (“CTF” or the “Foundation”) through sponsorship of the Foundation’s 2025 National Gala. The annual event, to be held November 17 at Gotham Hall in New York City, helps raise important funds to advance research and care developments while celebrating extraordinary progress in NF research and recognizing the individuals and partners driving progress toward ending NF (short for neurofibromatosis and schwannomatosis).

At this year’s gala, supporters like Jason Colodne and Colbeck Capital will honor the achievements of Dr. Richard Soll, who will receive the Cloud Carrier Award for his visionary leadership, global impact on drug discovery, and dedication to the NF community; Ken Walsh Jr., Heidi Cashell and Michael Cashell, who will be recognized for their impactful leadership as co-founders of the Colin Courageous Foundation; and Kate and Chad Doerge, who have built Penny’s Flight Foundation into a movement that fuels NF research and community support. Alexandra Norton, the 2026 Children’s Tumor Foundation National Ambassador, will be recognized for advocacy, courage, and commitment to raising NF awareness.

As the drug discovery engine for NF, the Children’s Tumor Foundation brings together patients, doctors, scientists, and pharma, driving treatments, advancing care, and delivering faster results for millions affected by neurofibromatosis or schwannomatosis. CTF’s patient-first collaborative approach accelerates drug development and brings life-changing therapies to patients faster – driven by its mission to end NF. To learn more about the gala, please click here.

About Colbeck Capital Management

Colbeck Capital Management (colbeck.com) is a leading, middle-market private credit manager focused on strategic lending. Colbeck originates senior secured loans to companies going through periods of transition, providing creative capital solutions. Colbeck sponsors its portfolio companies through consistent engagement with management teams in areas such as finance, capital markets and growth strategies, distinguishing itself from traditional lenders. Colbeck was founded in 2009 by Jason Colodne and Jason Beckman and currently manages $3+ billion of invested and committed capital. Colbeck’s principals have extensive experience investing through different market cycles at leading institutions, including Goldman Sachs and Morgan Stanley.